CIMT
Annual Meeting

Save the date:
May 12-14, 2025
Rheingoldhalle Congress Center Mainz, Germany

Europe's Cancer Immunotherapy Meeting

Speakers & Program

CIMT News

December 21, 2021
This is some text inside of a div block.

CIMT Annual Meeting 2022 program to again showcase hottest topics in cancer immunotherapy

From cutting-edge basic research to the latest translational applications, the 2022 CIMT Annual Meeting will again cover the latest advances in the field. Stay tuned for more information to be posted in January.

Read more
July 24, 2024
2024-07-24 15:38

21st CIMT Annual Meeting report

The meeting report of the 21st CIMT Annual Meeting has been published in Human Vaccines & Immunotherapeutics. DOI: 10.1080/21645515.2024.2381925

May 15, 2024
2024-05-15 11:11

The 21st CIMT Annual Meeting kicks off in Mainz, Germany

The 21st Annual Meeting of the Association for Cancer Immunotherapy (CIMT) has officially opened today in Mainz, Germany, drawing 870 participants from 32 countries.

May 14, 2024
2024-05-14 14:29

Abstracts of the 21st CIMT Annual Meeting

View the abstracts of the 21st CIMT Annunal Meeting at www.meeting.cimt.eu/speakers-and-program.

April 11, 2024
2024-04-11 12:42

Abstract presentation notifications have been sent.

If you have submitted an abstract, please check your email inbox, including your spam folder.

All conference abstracts will be published on this webseite and on the conference app on May 13.

March 8, 2024
2024-03-08 19:03

Abstract submission extended through March 15

The abstract submission for the 21st CIMT Annual Meeting has been extended through March 15 (CET).

February 15, 2024
2024-02-15 17:01

Abstract submission ends on March 8

Abstract submission for the 21st CIMT Annual Meeting is open through March 8, midnight CET.

January 11, 2024
2024-01-11 10:19

Abstract submission and registration is open

Abstract submission and registration for the 21st CIMT Annual Meeting is now open.

November 8, 2023
2023-11-08 14:36

2024 Industry Exhibit booking

Booth spaces are now available for the industry exhibit of the 21st CIMT Annual Meeting.

July 20, 2023
2023-07-20 10:05

CIMT 2024

Save the date for the 21st CIMT Annual Meeting: May 15-17, 2024

May 5, 2023
2023-05-12 13:46

2023 Poster Award Winners

Six early-career researchers were selected for poster awards at the 20th CIMT Annual Meeting.

May 3, 2023
2023-05-03 10:39

Annual Meeting opened with record attendance

The 20th CIMT Annual Meeting opened today with over 1,000 participants.

April 19, 2023
2023-04-20 9:14

Conference abstracts to be published on April 26.

All abstract titles and content of the 20th CIMT Annual Meeting will be published on April 26 at 10 a.m. (CET) at www.meeting.cimt.eu/speakers-and-program.

April 5, 2023
2023-04-05 15:53

CIMT Lifetime Achievement Award for Hans-Georg Rammensee

The German immunologist Hans-Georg Rammensee is the recipient of the 2023 CIMT Lifetime Achievement Award. He will be honored on Thursday, May 4, at 6 p.m., at the 20th CIMT Annual Meeting.

March 31, 2023
2023-03-31 15:01

Abstract notifications sent on March 30

If you have submitted an abstract, please check your email and your spam folder for your abstract notification email.

March 7, 2023
2023-03-07 10:27

300 abstracts submitted

More than 300 abstracts have been submitted to the 20th CIMT Annual Meeting and are currently being reviewed. Authors of highly rated abstracts will be invited to deliver short talks.

February 24, 2023
2023-02-24 17:45

New abstract submission deadline

The CIMT program meeting committee has extended the abstract submission to Friday, March 3 (midnight CET).

The advance conference registration will end on February 24.

February 1, 2023
2023-02-01 16:09

Advance registration ends February 24

Take advantage of best registration prices by registering through February 24. Further discounts apply to CIMT members.

January 4, 2023
2023-01-04 16:28

Abstract submission and registration

Abstract submission and registration will open on January 10, 2023.

December 1, 2022
2023-01-04 16:35

Rafi Ahmed will present keynote lecture of CIMT 2023

Rafi Ahmed of Emory University will present the keynote lecture of the 20th CIMT Annual Meeting on "cell lifestyle during chronic infection and cancer: implications for immunotherapy".

August 11, 2022
2022-08-11 12:16

CIMT 2023

Save the date for the 20th CIMT Annual Meeting on May 3-5, 2023.

May 12, 2022
2022-05-17 16:15

2022 Poster Award Winners

Seven early-career researchers were chosen by the CIMT poster jury members to receive the 2022 CIMT Poster Awards in six categories.

Read more
May 10, 2022
2022-05-10 15:16

CIMT 2022 opens in Mainz, Germany

The 2022 Annual Meeting today opened with over 700 international participants on-site and an additional livestream audience, totaling close to 1,000 attendees.

Read more
May 5, 2022
2022-05-05 16:11

COVID-19 protective measures

CIMT asks all on-site attendees to wear a surgical or FFP2/KN95 mask at the meeting.

Read more
April 21, 2022
2022-04-21 12:38

Detailed program schedule

A detailed program schedule with all 2022 speakers and talk titles is now published online.

Read more
April 13, 2022
2022-04-13 17:36

Poster and short talk presenters notified

All abstract authors have been notified about their scheduled poster presentations.

Read more
March 11, 2022
2022-03-11 13:42

New registration deadline

The advanced registration deadline has been extended through March 13, midnight (CET).

March 4, 2022
2022-03-07 9:22

Extended abstract submission deadline

The 2022 abstract submission deadline has been extended through March 13, midnight (CET).

January 21, 2022
2022-01-21 15:35

Abstract submission is open

The CIMT program committee is calling for abstract submission through March 4, 2022.

December 22, 2021
2021-12-22 12:27

CIMT Annual Meeting 2022

From cutting-edge basic research to the latest translational studies, the 2022 CIMT Annual Meeting will again cover the newest advances in the field.

Read more
September 17, 2021
2021-12-07 19:33

Save the Date for CIMT 2022

The 2022 CIMT Annual Meeting will take place May 10-12, 2022. More information will be posted as it becomes available.

read more
June 10, 2021
2021-12-07 19:35

On-demand viewing is available

The 2021 Annual Meeting sessions and eTalks have been available for on-demand viewing on the virtual event platform since May 31.

read more
May 19, 2021
2021-12-07 21:36

ACIR meeting summary

Selected talks from the virtual 18th CIMT Annual Meeting, including the keynote lecture by Ugur Sahin, were covered by ACIR. The meeting summary can be accessed on the ACIR web page.

read more
May 18, 2021
2021-12-07 21:36

On-demand session viewing

The Annual Meeting virtual platform is currently under construction. Thank you for your patience while we prepare the session talks for on-demand viewing. The platform will re-open at the end of May.

read more
May 14, 2021
2021-12-07 21:38

2021 eTalk Award Winners

Six early-career researchers have been chosen by the CIMT poster jury to receive the 2021 CIMT Poster Awards. One eTalk winner was selected by the meeting audience.

read more
May 10, 2021
2021-12-07 21:39

CIMT 2021 opens in Mainz, Germany

The virtual 18th Annual Meeting of the Association for Cancer Immunotherapy CIMT was opened  today by CIMT President Özlem Türeci  with over 800 academic and clinical professionals.

read more
May 3, 2021
2021-12-07 21:42

2021 abstracts are online

All abstracts and the day-to-day 2021 Annual Meeting program are online can be accessed at www.meeting.cimt.eu/speakers-and-program.

read more
April 28, 2021
2021-12-07 21:43

2021 CIMT Lifetime Achievement Award

The Italian immunologist Alberto Mantovani will be honored by CIMT for life-time achievements in cancer immunotherapy research.

read more
April 16, 2021
2021-12-07 21:43

Abstract authors have been notified

All abstract authors have been notified and have been sent information about setting up their presentations. The CIMT eTalk sessions will feature a total of 221 scientific eTalks.

read more
March 12, 2021
2021-12-07 21:44

Abstract submission extended to March 24

For late breaking abstracts, the 2021 abstract submission and advance registration has been extended to March 24 (midnight CET).

read more
February 25, 2021
2021-12-07 21:44

Apply for a registration waiver

CIMT will select young scientists from underrepresented countries for free conference admission. Free conference admission can only be extended to scientists under certain conditions.

read more
January 29, 2021
2021-12-07 21:45

2021 registration and abstract submission is open

For its virtual congress, the CIMT program committee is calling for abstract submission in six  categories: Therapeutic Vaccination, Cellular Therapy, New Targets and New Leads, and more.

read more
November 23, 2020
2021-12-07 21:46

2021 CIMT Annual Meeting

Save the date for the 2021 CIMT Annual Meeting which will take place in a virtual format, from May 10-12, 2021.

read more
March 20, 2020
2021-12-07 21:46

The 2020 CIMT Annual Meeting will not take place

The CIMT Executive Board has decided to not hold the CIMT Annual Meeting, which was scheduled for May 5-7, 2020, in Mainz, Germany.

read more

2025 Plenary Speakers

Ronald Germain
National Institutes of Health
USA
Stanley Qi
Stanford University
USA
Ilaria Elia
KU Leuven
Belgium
Matthew Spitzer
UC San Francisco
USA
Barbara Maier
CeMM Vienna
Austria
Dario Neri
Philogen/ETH Zurich
Switzerland
Susana Minguet
University of Freiburg
Germany
Hideho Okada
UC San Francisco
USA
David Gfeller
Ludwig Institute for Cancer Research Lausanne
Switzerland
Lukas Bunse
German Cancer Research Center DKFZ
All Speakers

Join the CIMT Experience

Every year, the CIMT Annual Meeting connects the global cancer immunotherapy community in the heart of Europe. As the largest meeting focused on cancer immunotherapy research and development in Europe, CIMT invites international participants for high-level scientific exchange, collaboration, and education focused on cancer immunotherapy.

Subscribe to the CIMT newsletter

Stay up to date on Europe’s largest meeting focused on cancer immunotherapy research and development

Our 2024 Supporters